Request for Comments on USPTO Initiatives To Promote Generic Drug and Biosimilar Competition
LexBlog IP
OCTOBER 25, 2022
How should the USPTO facilitate an applicant’s submission of prior art that is not accessible in the Patents End-to-End Search system ( g., “on sale” or prior public use)? 112, and whether the claims do not cover the same invention as a related application? Would a benchmark ( g.,
52 
Let's personalize your content